Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type

First Page		Document Content
Date: 2014-07-15 15:35:38 Health Anti-diabetic medication Diabetes management Diuretic Glycated hemoglobin Sulfonylurea Metformin Diabetes mellitus type 2 Diabetes mellitus Medicine Diabetes Endocrine system		Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type Add to Reading List Source URL: medsask.usask.ca Download Document from Source Website File Size: 324,29 KB Share Document on Facebook

	Management of Type 2 Diabetes in the South Asian Population: South Asian food: Friend or Foe? : Sangeeta Pradhan, RD, LDN, CDE South Asians are at a much higher risk for developing Type 2 diabetes, compared with some ot DocID: 1uxGv - View Document
	MINI REVIEW Diabetes Management Lysulin™, a new supplement for Nutritional Support for People with Diabetes and DocID: 1tZq7 - View Document
	Niagara Catholic District School Board DIABETES MANAGEMENT POLICY STATEMENT OF POLICY 300 – Schools/Students Adopted Date: June 12,2012 DocID: 1tdGr - View Document
	Diabetes Self-Management Plan Индивидуальный план мероприятий при диабете Ваш гемоглобин (HgbA1c) цель: DocID: 1sOUf - View Document
	“Good Diabetes Care” Tania Weng & Peter Diem Arbeitsgruppe Disease Management Diabetes der SGED DocID: 1sHAs - View Document